Ryan J. Selhorn
CIK: 0001670673
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AYTU BIOPHARMA, INC
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jul 28, 2026AYTU
AYTU BIOPHARMA, INC
Award(A)Direct25K shares- - Oct 3, 2025AYTU
AYTU BIOPHARMA, INC
Award(A)Direct16.2K shares- - Oct 3, 2025AYTU
AYTU BIOPHARMA, INC
Award(A)Direct17.5K shares- - Feb 5, 2025AYTU
AYTU BIOPHARMA, INC
Exercise(M)Direct105 shares- - Nov 11, 2024AYTU
AYTU BIOPHARMA, INC
Award(A)Direct14K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 28, 2026 | AYTU AYTU BIOPHARMA, INC | Award(A) | 25,000 | - | $0 | Direct |
| Oct 3, 2025 | AYTU AYTU BIOPHARMA, INC | Award(A) | 16,243 | - | - | Direct |
| Oct 3, 2025 | AYTU AYTU BIOPHARMA, INC | Award(A) | 17,500 | - | - | Direct |
| Feb 5, 2025 | AYTU AYTU BIOPHARMA, INC | Exercise(M) | 105 | - | - | Direct |
| Nov 11, 2024 | AYTU AYTU BIOPHARMA, INC | Award(A) | 14,000 | - | $0 | Direct |
1-5 of 5 transactions
About Selhorn Ryan J
Selhorn Ryan J (SEC CIK 0001670673) files insider reports with the SEC as Chief Financial Officer of AYTU BIOPHARMA, INC (AYTU).
Signal8 holds 5 ownership filings by Selhorn Ryan J (1 Form 3, 4 Form 4), filed between Nov 13, 2024 and Jul 30, 2026. Those filings report 5 transactions, from Nov 11, 2024 to Jul 28, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Selhorn Ryan J's filings is in DENVER, CO.
Recent filings by Selhorn Ryan J
Other insiders filing for AYTU BIOPHARMA, INC (AYTU)
- Disbrow Joshua R., Chief Executive Officer
- PYSZCZYMUKA GREG, Chief Commercial Officer
- Disbrow Jarrett, Chief Business Officer
- LIU VIVIAN H, Director
- JAIN ABHINAV, Director
- DOCKERY CARL, Director